Aurinia Pharmaceuticals (FRA:IKAP) Total Tax Payable : €1.3 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Aurinia Pharmaceuticals Total Tax Payable?

Aurinia Pharmaceuticals's Total Tax Payable for the quarter that ended in Mar. 2024 was €1.3 Mil.

Aurinia Pharmaceuticals's quarterly Total Tax Payable increased from Sep. 2023 (€0.2 Mil) to Dec. 2023 (€0.6 Mil) and increased from Dec. 2023 (€0.6 Mil) to Mar. 2024 (€1.3 Mil).

Aurinia Pharmaceuticals's annual Total Tax Payable declined from Dec. 2021 (€0.7 Mil) to Dec. 2022 (€0.6 Mil) but then increased from Dec. 2022 (€0.6 Mil) to Dec. 2023 (€0.6 Mil).

Aurinia Pharmaceuticals Total Tax Payable Historical Data

The historical data trend for Aurinia Pharmaceuticals's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurinia Pharmaceuticals Total Tax Payable Chart

Aurinia Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

0.72

0.59

0.61

Aurinia Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial															0.99	0.13	0.21	0.61	1.30

Aurinia Pharmaceuticals Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Aurinia Pharmaceuticals Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Aurinia Pharmaceuticals's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurinia Pharmaceuticals (FRA:IKAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurinia Pharmaceuticals Inc (FRA:IKAP) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

AUPH:USA IKAP:Germany

Address

4464 Markham Street, Suite 1203, Victoria, BC, CAN, V8Z 7X8

Website

https://www.auriniapharma.com

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Aurinia Pharmaceuticals (FRA:IKAP) Headlines

No Headlines